Results 231 to 240 of about 7,556 (242)
Efficacy and safety of nirsevimab for preventing respiratory syncytial virus infection in infants: an updated systematic review and meta-analysis encompassing 11,001 participants. [PDF]
Tanashat M+5 more
europepmc +1 more source
Identification of a direct interaction between the Fab domains of IgG antibodies and human FcRn upon IgG-FcRn complex formation. [PDF]
Trabjerg E+5 more
europepmc +1 more source
Ucenprubart is an agonistic antibody to CD200R with the potential to treat inflammatory skin disease: preclinical development and a phase 1 clinical study. [PDF]
Koester A+19 more
europepmc +1 more source
A Novel Dual-Fc Bispecific Antibody with Enhanced Fc Effector Function. [PDF]
Zhou F+10 more
europepmc +1 more source
Efanesoctocog alfa: the renaissance of Factor VIII replacement therapy.
Dargaud Y+3 more
europepmc +1 more source
The cell surface protein CD83 belongs to the immunoglobulin superfamily and is highly expressed on mature dendritic cells. The soluble form of CD83, sCD83, is a potential immune suppressor. In a previous study, recombinant soluble CD83 was expressed in Escherichia coli, resulting in a lack of functional glycosylation.
Yuan, Y.+9 more
openaire +5 more sources
3.5 Elevated Levels of Both Membrane-Bound and Soluble Forms of a Receptor Specific for the Fragment Crystallizable Region of Immunoglobulin M in Patients with CLL Fu Jun Li, Yoshiki Kubagawa, Matthew K. McCollum, Landon Wilson, Tomoko Motohashi, Luigi F. Bertoli, James C. Barton, Stephen Barnes, Randall S.
Fu Jun Li+9 more
openaire +3 more sources
Expression, purification, crystallization of fragments from the C-terminal region of DFF45/ICAD
Haitao Ding+5 more
openalex +1 more source